why choose us

First received: May 17, 2023

Clinical Trial: CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Primary Biliary Cholangitis (PBC)

Study Type: INTERVENTIONAL


Official Title: A Phase II Study to Evaluate Safety, Tolerability and Efficacy, of CS0159 in Patients Subjects With PBC (Primary Biliary Cholangitis), Multicenter, Randomized 12-week, Double-blind, Placebo-controlled

Brief Summary: A phase II study to evaluate safety, tolerability and efficacy of CS0159 in patients with PBC (Primary Biliary Cholangitis).

Read more